CardioOne Partners With DeepScribe to Bring Cardiology-specific Ambient AI to Practices
The collaboration furthers CardioOne's mission to support independent cardiologists with DeepScribe's AI documentation in the exam room
DeepScribe AI technology will automatically document key elements of cardiology notes, including cardiology-specific HPI (History of Present Illness) and ICD-10 diagnosis codes. Also included is a cardiac history section summarizing relevant cardiac medical and surgical history, family history, test results, and imaging studies.
Clinicians can be fully present with their patients as DeepScribe ambient AI turns each patient conversation into a complete, accurate note, empowering each medical practice to achieve quality and value-based goals.
"We are thrilled to partner with DeepScribe to provide this essential service to our partner physicians," said
The initial CardioOne rollout of DeepScribe – at the group Cardiovascular Specialists of
"It is a privilege to partner with CardioOne, to bring their clinicians documentation that makes their lives easier," said
The CardioOne-DeepScribe partnership underscores a shared, concerted commitment: leveraging technology to help transform care delivery. By integrating DeepScribe's specialized clinical documentation capabilities, CardioOne continues to empower independent cardiologists to become more efficient, remove administrative work, and focus on exceptional patient care.
"In cardiovascular care, as with many specialties, specificity in the patient chart is critical," said Dean Dalili, MD, MHCM, Chief Medical Officer at DeepScribe. "Our custom cardiology AI model produces specific terminology, details, billing codes – while each clinician can customize their notes. This all leads to less time charting, more time with each patient, and a more meaningful note output for care."
About DeepScribe
DeepScribe helps clinicians make the most of every encounter with ambient AI technology that transforms patient conversations into complete, accurate documentation and real-time insights. Founded in 2017, DeepScribe has trained its AI platform on more than five million patient conversations to adapt to the specific needs of each specialty, and manage even the most complex cases. Working closely with clinicians and healthcare industry leaders, DeepScribe delivers custom AI models to ensure greater accuracy, efficiency, and clinician satisfaction. To see how DeepScribe brings the joy of care back to medicine, visit deepscribe.ai.
About CardioOne
Launched in 2023, CardioOne is a cardiology-focused care delivery enablement company that offers technology and administrative support to independent cardiologists moving into the value-based care space. Through its comprehensive technology platform that is uniquely tailored to the specific workflows of cardiologists, CardioOne allows clinicians to focus on delivering high quality patient care while receiving support on the administrative functions within their practices. CardioOne's mission is to ensure that local cardiologists have the necessary tools and support to maintain their independence while also thriving in an increasingly demanding practice environment. For more information, please visit www.cardioone.com.
For media inquiries, please contact:
[email protected]
978.771.9976
View original content to download multimedia:https://www.prnewswire.com/news-releases/cardioone-partners-with-deepscribe-to-bring-cardiology-specific-ambient-ai-to-practices-302275931.html
SOURCE DeepScribe
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kaigene Enters into Exclusive Licensing Agreement with Taisho Pharmaceutical for Next-Generation Autoimmune Asset KG006 in Japan
- Agentio Turns YouTube Creator Advertising Into a Scalable Growth Engine for SURI's U.S. Expansion
- Omni Bridgeway Releases 4Q26 Portfolio Update with Record FY26 Commitments and Investment Proceeds
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share